Carlos Estévez, the Royals' reliever, is set to undergo shoulder surgery next week, as revealed by manager Matt Quatraro. This procedure, described as 'somewhat exploratory', will provide more clarity on Estévez's future after a challenging season. Estévez's journey has been a rollercoaster, from his impressive All-Star performance last year to a recent rotator cuff strain diagnosis in May. Despite his efforts to rehab, the surgery is now necessary, marking a significant setback for the Royals' bullpen.
Estévez's season took a turn for the worse when he gave up six runs in his only appearance this year, including a walk-off grand slam by Dominic Smith. This performance followed a concerning trend, as his velocity had been down during Spring Training and the World Baseball Classic. The Royals' bullpen struggles have been well-documented, with a high ERA and low strikeout rate, further exacerbated by Estévez's absence.
The Royals' decision to decline Estévez's $13MM club option in favor of a $2MM buyout will likely impact his future in the MLB. His performance and the specifics of the surgery will determine his market value. Estévez's potential return to free agency raises questions about his role in the Royals' future plans and his ability to secure a major league contract.
This situation highlights the challenges faced by players and teams in the MLB, where a single season can significantly influence a player's career trajectory. Estévez's story serves as a reminder of the delicate balance between talent, health, and opportunity in professional sports.
